H.I.G. Capital Expands Its Capital Formation Team with the Addition of Alejandra Arguello
NEW YORK–(BUSINESS WIRE)–#AlternativeInvestmentManagement–H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with $50 billion…
Year: 2022
Zayo Unleashes the Power of Zeus
Customers can access the most secure, direct and reliable fibre connection between the UK and…
Double Monza podium for TOYOTA GAZOO Racing
TOKYO, Jul 11, 2022 – (JCN Newswire) – TOYOTA GAZOO Racing earned a dramatic double…
Hitachi Energy supplies world-breaking OceaniQ subsea transformers to OneSubsea for its subsea multiphase compression system
ZURICH, SWITZERLAND, Jul 11, 2022 – (JCN Newswire) – Hitachi Energy has today started testing…
CEA International LLP Advises GMEX Group on its Acquisition of Pyctor Digital Assets Technology from ING
TAMPA, Fla. & LONDON–(BUSINESS WIRE)–#finance—CEA International LLP (“CEAI”) advises GMEX Group Limited (“GMEX”) on the…
Whiskey & Wealth Club Wins Landmark Dismissal and Retraction of False Allegations by Texas State Securities Board
Securities Commissioner says the Dublin & London-based wholesaler is not in breach of securities law…
Pliant Therapeutics Announces Positive Safety and Efficacy Data from Phase 2a INTEGRIS-IPF Clinical Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis
Figure 1 Change in FVC Over 12 Weeks in INTEGRIS-IPF; Mixed Model Repeat Measures Analysis…
One Immortl to Release Dividend Yielding NFTs From Real Cafés
It’s not just a Loyalty Program – It’s a Lifestyle – #WeAreImmortl Change The Way…
Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors
Data presented today show a reduction in treated spontaneous and traumatic bleeds and mean annualised…
Press Release: Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis
Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or…
Press Release: Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis
Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis…
JC Sports Houston Youth Team Athletics Center Announces Eighth Anniversary
JC Sports Houston, a youth sports development organization serving the Greater Houston area, has announced…
Ful.io Launches Upgraded Business Intelligence Tools for Small and Medium Businesses
Ful.io recently upgraded its services to better help businesses uncover the technographic data used by…
Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress
FLT180a generated protective FIX levels with no bleeding or need for FIX replacement The treatment…
LBank Exchange Will List Block Duelers (BDTX) on July 9, 2022
Internet City, Dubai–(Newsfile Corp. – July 9, 2022) – LBank Exchange, a global digital asset…
LBank Exchange Will List Dasoo (DSO) on July 8, 2022
Internet City, Dubai–(Newsfile Corp. – July 9, 2022) – LBank Exchange, a global digital asset…
Rimaunangis SDN BHD Partnership with Sangkara Misa Builds Malaysia’s First Agriculture Metaverse
Kuala Lumpur, Malaysia–(Newsfile Corp. – July 9, 2022) – Rimaunangis SDN BHD partners with Sangkara…
UPSTART DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Upstart Holdings, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds…
CORRECTING and REPLACING Spirit Airlines Announces Intention to Adjourn Special Meeting of Stockholders
Company Intends to Continue Discussions with Frontier and JetBlue Spirit Will Continue to Solicit Proxies…
MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus Checkpoint Inhibition in Head and Neck Cancer
ROCKVILLE, MD, July 08, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused…